AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $412,804 | -33.6% | 5,128 | -34.1% | 0.00% | -50.0% |
Q1 2024 | $621,243 | +28.1% | 7,785 | +27.7% | 0.00% | 0.0% |
Q4 2023 | $485,021 | -12.1% | 6,094 | -22.8% | 0.00% | -20.0% |
Q3 2023 | $551,851 | -19.1% | 7,896 | -16.8% | 0.01% | -28.6% |
Q2 2023 | $681,808 | +12.8% | 9,488 | -3.2% | 0.01% | 0.0% |
Q1 2023 | $604,587 | -3.0% | 9,802 | +21.3% | 0.01% | +16.7% |
Q4 2022 | $623,442 | -99.9% | 8,083 | -60.4% | 0.01% | +20.0% |
Q3 2022 | $456,456,000 | +83961.9% | 20,434 | +44.2% | 0.01% | -16.7% |
Q2 2022 | $543,000 | +36.8% | 14,169 | +47.7% | 0.01% | +50.0% |
Q1 2022 | $397,000 | +68.2% | 9,595 | +53.4% | 0.00% | +100.0% |
Q4 2021 | $236,000 | +12.4% | 6,254 | -2.0% | 0.00% | 0.0% |
Q3 2021 | $210,000 | -44.4% | 6,384 | +14.0% | 0.00% | -50.0% |
Q2 2021 | $378,000 | +68.0% | 5,600 | +41.0% | 0.00% | +33.3% |
Q1 2021 | $225,000 | – | 3,973 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |